Supplementary Figure S3 from Preclinical Activity of the B7-H3–Targeting Antibody–Drug Conjugate Vobramitamab Duocarmazine in Pediatric Solid Tumors

Authors: Edward Favours, Haiying Tang, Peyton Wong et al.

Publication:

Published: Unknown date

Source: Crossref

Back to Search View Original Cite This Article

Abstract

<jats:p><p>Plots of event-free-survival (EFS) and relative tumor volume (RTV) changes over time for Ewing sarcoma models. Treatment groups: A = control, B = vobra duo: 6 mg/kg, IP, Day 0 × 1, C=SYD988: 6 mg/kg, IP, Day 0 × 1. Bold lines on RTV plots represent group median tumor volume changes.</p></jats:p>

Keywords

tumor volume mgkg pplots eventfreesurvival

Supplementary Figure S3 from Preclinical Activity of the B7-H3–Targeting Antibody–Drug Conjugate Vobramitamab Duocarmazine in Pediatric Solid Tumors

Abstract

Keywords

Related Articles

From task models to world models: A person-specific computational psychology of anxiety

From Status to Soul: Gendered Ideals and Quests for Compatibility in Contemporary Relationships

Awareness in Decoded Neurofeedback: Meta-Analytic Evidence from Forced-Choice Judgments and Semantic Analysis of Verbal Reports Using Large Language Models

Supplemental Material: Geomagnetic field intensity from prehispanic material since 1400 BCE to 1500 CE, central Mexico

Azimuthal Anisotropy and Lateral Velocity Gradient Beneath Australia From Teleseismic P-wave Polarization Anomalies